Synthetic EPO Erythropoietin Injection
EPO is a protein hormone produced by the kidney. It binds with receptors in the bone marrow after being released into blood stream, and stimulates the production of red blood cells (erythrocytes).
EPO is produced by interstitial fibroblasts in the kidney closely associated with peritubular capillary and tubular epithelial tubule and it's also derived from perisinusoidal cells in the liver. Although liver production predominating during fetal and perinatal period, renal production is predominant during adulthood. Except for erythropoiesis, erythropoietin also has other known biological functions. For instance, it plays an essential role in the brain's response to neuronal injury. EPO is also well known for its wound healing ability.
Specifications:
When exogenous EPO is used as a performance-enhancing drug, it is classified as an erythropoiesis-stimulating agent (ESA). Exogenous EPO can often be detected in blood, due to slight difference from the endogenous protein, for example in features of posttranslational modification.
EPO is able to prevent metabolic alterations, neuronal and vascular degeneration, and inflammatory cell activation. Accordingly, EPO may be a therapy used for a variety of disorders. Erythropoietin's major functions are: Promoting the development of red blood cells
Initiating the sythesis of hemoglobin, the molecule within red blood cells that transports oxygen.
